Dietary melanoidins themselves produce various effects in the organism: they decrease Phase I liver enzyme activity and promote glycation in vivo, which may contribute to diabetes, reduced vascular compliance and Alzheimer's disease.
Melanoidins produced by dietary intake have several consequences for the body: they reduce liver enzyme activity and induce glycation in living organisms, potentially leading to diabetes, decreased blood vessel flexibility, and Alzheimer's disease.